Navy

Equine Research Awards

A Commitment to Equine Disease Research

Scientists, researchers, practicing veterinarians, animal health companies and horse owners have long been dedicated to improving the health of the horse. Yet the need for more knowledge in regards to disease prevention, lameness and general wellness still exists.

 

Boehringer Ingelheim provides five $15,000 awards annually to researchers whose proposals help to advance the diagnosis, treatment and understanding of equine infectious disease(s). 

 

Art of Performance

About the Award

Veterinarians, diagnosticians, public and private researchers in the United States and Canada are eligible to submit proposals for research programs that advance diagnosis, treatment and understanding of equine infectious disease(s). Residents and DVM/VMD graduate students will be given preferential consideration for two of the five grants if proposals are deemed adequate merit. 

About the Award

Veterinarians, diagnosticians, public and private researchers in the United States and Canada are eligible to submit proposals for research programs that advance diagnosis, treatment and understanding of equine infectious disease(s). Residents and DVM/VMD graduate students will be given preferential consideration for two of the five grants if proposals are deemed adequate merit. 

Art of Performance
Gray box

2022 Proposals Due

The deadline for proposals for the 2022 Advancement in Equine Research Award is: September 15, 2022

Full Research Award Details

 

Objectives

  1. To provide a venue for Boehringer Ingelheim to sponsor equine disease research for the benefit of the equine industry
  2. To encourage interaction among equine researchers and practitioners
  3. To enhance knowledge and communication of new information to the industry
  4. To reward research excellence

 

 

Research Focus

The 2022 research topic Equine Respiratory Disease with suggested areas of research focused on:

  1. Equine Infectious Respiratory Disease
  2. Equine Asthma Syndrome

 

 

Eligibility

  • Veterinary residents and DVM/VMD graduate students
  • Researchers 
  • Diagnosticians 
  • Animal Scientists 
  • Practitioners

 

Eligibility for participation to include anyone in United States, Canada and Mexico. 

 

 

Basic Requirements

  • Research must have the potential to generate new information that has clear relevance to the designated research topic
  • The proposal must have a timeline including start date and completion date (maximum 12 months following initial funding)
  • The proposal should target an oral presentation at AAEP, ACVIM or other professional venue(s)
  • Application must comply with the format provided by the Advancement in Equine Research  Review Board

 

 

Selection Criteria

The Advancement in Equine Research Review Board acting on its own, without influence from the sponsoring company, will peer review and select proposals based on the following criteria:

  • Probability of successfully completing the project
  • Potential for impact to the equine industry
  • Originality
  • Scientific quality

 

 

The Advancement in Equine Research Review Board Members

The independent Review Board has revolving seats to ensure the Board remains impartial and infused with new ideas. The renowned members consist of equine industry professionals including practicing veterinarians and researchers.

  • Tom Divers, DVM, DACVIM, DACVECC
  • Rob Franklin, DVM, DACVIM
  • Heather Knych, DVM, PhD, DACVCP
  • Nathan Slovis, DVM, DACVIM, CHT
  • Julie Wilson, DVM, DACVIM

 

 

Confidentiality of Proposals

  • The Board agrees not to discuss proposals outside the venue
  • The Board members have signed a confidentiality agreement regarding information disclosure, which will be provided upon request
  • Boehringer Ingelheim personnel, who will manage the practical collection of proposals, will comply with the same level of confidentiality as the Board members

 

 

Board Member Conflict of Interest

The Board members will not participate in the review and evaluation of any proposals or subsequent manuscripts for which they are investigators or authors, respectively.

 

 

Application Procedure

Please visit the full proposal instructions page for more details, and to download application forms. All proposals must comply with application instructions and be submitted via e-mail to steve.grubbs@boehringer-ingelheim.com.

 

©2022 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-EQU-0135-2021A-V2

Full Award Submission Instructions